Cargando…

Response to microtubule-interacting agents in primary epithelial ovarian cancer cells

BACKGROUND: Ovarian cancer constitutes nearly 4% of all cancers among women and is the leading cause of death from gynecologic malignancies in the Western world. Standard first line adjuvant chemotherapy treatments include Paclitaxel (Taxol) and platinum-based agents. Taxol, epothilone B (EpoB) and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pellicciotta, Ilenia, Yang, Chia-Ping Huang, Venditti, Charis A, Goldberg, Gary L, Shahabi, Shohreh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711894/ https://www.ncbi.nlm.nih.gov/pubmed/23574945 http://dx.doi.org/10.1186/1475-2867-13-33

Ejemplares similares

Presence of both Mesenchymal and Carcinomatous Features in an In-vitro Model of Ovarian Carcinosarcoma Derived from Patients' Ascitic Fluid
por: Shariftabrizi, Ahmad, et al.
Publicado: (2015)

Clinical utility of chromogranin A and octreotide in large cell neuro endocrine carcinoma of the uterine corpus
por: Shahabi, Shohreh, et al.
Publicado: (2011)

Long-term primary culture of a clear cell ovarian carcinoma reveals an epithelial–mesenchymal cooperative interaction
por: Goyeneche, Alicia A., et al.
Publicado: (2015)

BRCA1 Zinc RING Finger Domain Disruption Alters Caspase Response in Ovarian Surface Epithelial Cells
por: Johnson, Nicole C, et al.
Publicado: (2002)

Ovarian cyst removal influences ovarian reserve dependent on histology, size and type of operation
por: Henes, Melanie, et al.
Publicado: (2018)

Metabolome analysis reveals a diversity of cancer tissues in advanced epithelial ovarian cancer
por: Yoshida, Kosuke, et al.
Publicado: (2021)

HHLA2 predicts better survival and exhibits inhibited proliferation in epithelial ovarian cancer
por: Xu, Guocai, et al.
Publicado: (2021)

miR-206 as a prognostic and sensitivity biomarker for platinum chemotherapy in epithelial ovarian cancer
por: Yu, Xiaotang, et al.
Publicado: (2020)

Recent Advancements in Prognostic Factors of Epithelial Ovarian Carcinoma
por: Ezzati, Mohammad, et al.
Publicado: (2014)

RIPK1 polymorphisms and expression levels: impact on genetic susceptibility and clinical outcome of epithelial ovarian cancer
por: Wang, Xuedong, et al.
Publicado: (2023)

Pentraxin 3 is a diagnostic and prognostic marker for ovarian epithelial cancer patients based on comprehensive bioinformatics and experiments
por: Chang, Xiaoying, et al.
Publicado: (2021)

KIAA0101, a target gene of miR-429, enhances migration and chemoresistance of epithelial ovarian cancer cells
por: Chen, Hong, et al.
Publicado: (2016)

Enhanced expression of microtubule-associated protein 7 functioned as a contributor to cervical cancer cell migration and is predictive of adverse prognosis
por: Tang, Ning, et al.
Publicado: (2020)

Suppression of endothelial cell migration by tumor associated macrophage-derived exosomes is reversed by epithelial ovarian cancer exosomal lncRNA
por: Wu, Quanfeng, et al.
Publicado: (2017)

MiR-596 activated by EP300 controls the tumorigenesis in epithelial ovarian cancer by declining BRD4 and KPNA4
por: Wang, Deying, et al.
Publicado: (2020)

Tumor cell response to bevacizumab single agent therapy in vitro
por: Hein, Melanie, et al.
Publicado: (2013)

Dynamic and influential interaction of cancer cells with normal epithelial cells in 3D culture
por: Ivers, Laura P, et al.
Publicado: (2014)

Taxol(®): The First Microtubule Stabilizing Agent
por: Yang, Chia-Ping Huang, et al.
Publicado: (2017)

Downregulated lincRNA HOTAIR expression in ovarian cancer stem cells decreases its tumorgeniesis and metastasis by inhibiting epithelial-mesenchymal transition
por: Wang, Jing, et al.
Publicado: (2015)

Low BCL9 expression inhibited ovarian epithelial malignant tumor progression by decreasing proliferation, migration, and increasing apoptosis to cancer cells
por: Wang, Jing, et al.
Publicado: (2019)

Predictive value of RAD51 on the survival and drug responsiveness of ovarian cancer
por: Feng, Yuchen, et al.
Publicado: (2021)

Expression of microtubule-associated protein TPX2 in human gastric carcinoma and its prognostic significance
por: Shao, Cuijie, et al.
Publicado: (2016)

Stromal-epithelial responses to fractionated radiotherapy in a breast cancer microenvironment
por: Qayyum, Muqeem A., et al.
Publicado: (2015)

Different TP53 mutants in p53 overexpressed epithelial ovarian carcinoma can be associated both with altered and unaltered glycolytic and apoptotic profiles
por: Antoun, Stephanie, et al.
Publicado: (2018)

Novel sulphamoylated 2-methoxy estradiol derivatives inhibit breast cancer migration by disrupting microtubule turnover and organization
por: van Vuuren, Rustelle Janse, et al.
Publicado: (2019)

Combination of tunicamycin with anticancer drugs synergistically enhances their toxicity in multidrug-resistant human ovarian cystadenocarcinoma cells
por: Hiss, Donavon C, et al.
Publicado: (2007)

Mitochondrial structure alteration in human prostate cancer cells upon initial interaction with a chemopreventive agent phenethyl isothiocyanate
por: Xue, Chengsen, et al.
Publicado: (2014)

High-grade serous ovarian cancer cell lines exhibit heterogeneous responses to growth factor stimulation
por: Bourgeois, Danielle L., et al.
Publicado: (2015)

Activation of p53, inhibition of telomerase activity and induction of estrogen receptor beta are associated with the anti-growth effects of combination of ovarian hormones and retinoids in immortalized human mammary epithelial cells
por: Zhang, Jiahui, et al.
Publicado: (2005)

LINC00152 upregulates ZEB1 expression and enhances epithelial-mesenchymal transition and oxaliplatin resistance in esophageal cancer by interacting with EZH2
por: Zhang, Shuyao, et al.
Publicado: (2020)

Kaempferol enhances cisplatin's effect on ovarian cancer cells through promoting apoptosis caused by down regulation of cMyc
por: Luo, Haitao, et al.
Publicado: (2010)

Suramin inhibits cell proliferation in ovarian and cervical cancer by downregulating heparanase expression
por: Li, HuaPing, et al.
Publicado: (2015)

YWHAE as an HE4 interacting protein can influence the malignant behaviour of ovarian cancer by regulating the PI3K/AKT and MAPK pathways
por: Li, Xiao, et al.
Publicado: (2021)

Comprehensive analysis of LDHAP5 pseudogene expression and potential pathogenesis in ovarian serous cystadenocarcinoma
por: Lin, Shitong, et al.
Publicado: (2020)

Increased cell survival by inhibition of BRCA1 using an antisense approach in an estrogen responsive ovarian carcinoma cell line
por: Annab, Lois A, et al.
Publicado: (2000)

Model constructions of chemosensitivity and prognosis of high grade serous ovarian cancer based on evaluation of immune microenvironment and immune response
por: Zhang, Han, et al.
Publicado: (2021)

Pepsin promotes IL-8 signaling-induced epithelial–mesenchymal transition in laryngeal carcinoma
por: Tan, Jia-Jie, et al.
Publicado: (2019)

Cytokine profiles and Lactobacillus species presence in pre-menopausal subjects with genital Mycoplasma genitalium or Ureaplasma urealyticum colonization
por: Garza, John, et al.
Publicado: (2021)

MicroRNA-23a regulates epithelial-to-mesenchymal transition in endometrial endometrioid adenocarcinoma by targeting SMAD3
por: Liu, Ping, et al.
Publicado: (2016)

Expression of PAWR predicts prognosis of ovarian cancer
por: Tan, Jiahong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o7sddd03sokio2im3lhaubd987